Open to All, Care for All.

我们的理念是面向研究者的“开放”,以及面向患者的“关怀”。我们的方法论是基于以病人为中心的转化医学研究原则,利用多阶段、多学科、多尺度的生物医药大数据,针对药物研发项目的药物设计与研发策略优化建立一套灵活、可整合的人工智能系统。利用先进的数据整合科技和人工智能算法,旨在药物研发各个阶段的转化鸿沟上搭建信息和决策桥梁。希望通过建立实验与模型计算之间最有效的迭代和研发模式来提升药物管线的成功率,满足未被满足的临床需求。

Our mission is open to all researchers and care for all patients. Our methodology is based on the principle of patient-centered translational medicine research, using multi-stage, multi-disciplinary and multi-scale biomedical big data, aiming at drug design and R&D strategy optimization, to establish a flexible and integrated artificial intelligence system. Using advanced data integration technology and artificial intelligence algorithms, it aims to build an information and decision-making bridge on the translational gaps of drug discovery and development at all stages. We hope to improve the success rate of drug pipeline and meet the unmet clinical needs by establishing an effective iteration between experimental and computational sciences.

A small molecule screening and designing platform leveraging multiscale AI modeling of binding assays, enzymatic assays, cellular assays, tissue assays, and pharmacogenomics data as well as de novo design capabilities.Please check our current free release including COVID-19, ADMET, etc…..

ParadiChem®

Small Molecule Drug Discovery

An integrated therapeutic protein computational workflow for in silico affinity maturation, immunogenicity prediction, and thermostability prediction to systematically optimize the therapeutic window of antibodies and other biological therapeutics.(under development)

ParadiBio®

Biologics Discovery Platform

A set of natural language processing tools and workflows featuring one click text mining for domain knowledge such as quantitative assays results, disease-gene association analysis, and patent searches.Please check our current applications: COVID-19 preclinical studies , COVID-19 publication feeds

ParadiSearch®

Scientific Intelligence NLP Platform

A data-driven analytic workflow to support drug target identification and prioritization, facilitate disease mechanism understanding, and recommend personalized treatment plans by leveraging biological big data, advanced AI, and bioinformatics techniques.(under development)

ParadiMed®

Precision Medicine Platform

A systematic utilization of biomedical big data and advanced AI engineering to revolutionize drug discovery. The system has automatically trained thousands of AI predictive models for drug design and scientific decision support.

PhaseX®

AI System For Next Generation Drug Discovery


Our Current Free Release including COVID-19, ADMET, etc…..
GHDDI's Free AI Virtual Screening Service for COVID-19
LEARN MORE >
GHDDI's Free ADMET Prediction Service
LEARN MORE >
GHDDI's Free Structure based Prediction Service
LEARN MORE >
GHDDI's Free Large Scale Biochemical AI Matrix Dashboard
LEARN MORE >

For any request, please contact us